Travere Therapeutics, Inc. (TVTX) Analyst Forecast

$17.08

south_east
-$1.51 (-8.12%)
Day's range
$16.8
Day's range
$18.76

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
10/31/2024 Evercore ISI Liisa Bayko $33.00 $17.50   88.57%
10/21/2024 Wells Fargo Mohit Bansal $27.00 $17.87   51.09%
10/10/2024 Evercore ISI Liisa Bayko $30.00 $18.07   66.02%
10/09/2024 Bank of America Securities Jason Zemansky $20.00 $15.21   31.49%
10/01/2024 Barclays Carter Gould $18.00 $13.99   28.66%
09/27/2024 Guggenheim Vamil Divan $23.00 $15.04   52.93%
09/27/2024 H.C. Wainwright Ed Arce $18.00 $15.04   19.68%
09/27/2024 Bank of America Securities Greg Harrison $18.00 $14.01   28.48%
09/10/2024 Canaccord Genuity Ed Nash $23.00 $12.70   81.17%
09/09/2024 Guggenheim Vamil Divan $25.00 $6.31   296.2%
08/28/2024 Piper Sandler Nicole Gabreski $12.00 $8.96   33.93%
08/02/2024 H.C. Wainwright Ed Arce $20.00 $4.62   332.9%
05/07/2024 Canaccord Genuity Ed Nash $18.00 $3.28   448.78%
04/24/2024 H.C. Wainwright Ed Arce $19.00 $2.74   593.43%

Travere Therapeutics, Inc. FAQ's

What analysts cover Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. has been rated by research analysts at Evercore ISI, Wells Fargo, Bank of America Securities, Barclays, Guggenheim, H.C. Wainwright in the past 90 days.